Brief: NeuBase Therapeutics Announces Pricing Of $40 Million Public Offering Of Common Stock
22/04/2021 14:08
April 22 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS ANNOUNCES PRICING OF $40 MILLION
PUBLIC
OFFERING OF COMMON STOCK
* NEUBASE THERAPEUTICS INC - PRICING OFFERING AT A PRICE TO
PUBLIC
OF $5.00 PER SHARE
Source text for Eikon: ID:nGNX72CVw3
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet